BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2006
View Archived Issues
Plasmacytoid DCs regarded as targets for microbicides
Read More
Novel dual PPARgamma/delta agonist controls dyslipidemia and hyperglycemia in diabetes
Read More
Recent Vernalis patent reports novel analgesic agents
Read More
Novel agents for treating neurological disorders disclosed in recent patent literature
Read More
Recent patents report novel therapeutic agents for hepatitis C virus infection
Read More
New peptidomimetic C5a receptor antagonist displays superior selectivity and in vivo activity
Read More
Ingested SIRS effective in preclinical models of type 1 diabetes and EAE
Read More
Gabapentin may be effective in treatment of neurogenic overactive bladder
Read More
Recent patents describe new treatment strategies for diabetes
Read More
Novogen offers overview of year's highlights
Read More
Allos completes enrollment in pivotal study of Efaproxyn
Read More
MedImmune and Infinity team up to develop small molecule cancer drugs
Read More
Colazal receives pediatric exclusivity
Read More
Milestones at BioMarin
Read More
SGX discontinues phase II/III study of Troxatyl in third-line AML
Read More
Enrollment completed in U.S. phase III study of Aridol
Read More
Six-week follow-up completed in study of Cethrin in acute spinal cord injury
Read More
Sinovac Biotech reports preliminary phase I trial of pandemic influenza vaccine
Read More
Nigerian phase III study of Savvy ended early
Read More
Rituxan shows benefit in relapsing-remitting MS
Read More
Extina shows non-inferiority versus ketoconazole cream in seborrheic dermatitis
Read More
Review extended for desvenlafaxine succinate NDA
Read More
Gestiva recommended for approval to prevent preterm birth
Read More
E.U. approval for Exjade
Read More
Advances in anti-HIV microbicides reported at the recent AIDS conference
Read More
Resistance to peginterferon/ribavirin conferred by increased expression of interferon genes
Read More
ITMN-191 continues preclinical development, clinical trials warranted
Read More
Rapamycin shows efficacy against Listeria monocytogenes infection in mice
Read More